Vaccine and Infectious Disease Division
Our researchers are working to reduce the burden of cancers around the world through improved diagnosis, better prevention strategies and optimized treatment plans. To address these cancers we are focusing on the support of research, clinical care and training of cancer specialists, scientists and support staff in Uganda and other countries. The cornerstone of our research and clinical work in global oncology is our decade-long collaboration with the Uganda Cancer Institute (UCI) in Kampala, Uganda.
Researchers in this group work to detect, prevent and treat the infectious disease complications of immunocompromised individuals, examine the role of infections in the development of cancers and study the role of the microbiome in disease pathogenesis and outcome.
Scientists here focus on immunopathogenesis and host genetics, vaccine immune monitoring and HIV vaccine and adjuvant design. Research in this discipline is focused on translating fundamental knowledge about the immune system and its regulation to the design of vaccine reagents and regimens that induce broader and more effective responses and to the development of novel therapies for cancer, HIV, tuberculosis, malaria and other related infectious diseases.
Using math modeling, epidemiology and statistics, scientists determine how infectious diseases are spread and contained. Our researchers are creating a platform for integrated research that allows biostatistics, bioinformatics and population modeling to be engaged throughout vaccine design, development, evaluation and implementation.